Tatyana Plachco1, Romina Libster2,3,4, Jodell E Linder4, Lucrecia Bossi1, Norma Aspres5, Gabriela Bauer1, John V Williams4, Fernando P Polack2,4, E Kathryn Miller4. 1. Hospital de Pediatria SAMIC Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. 2. Fundacion INFANT, Buenos Aires, Argentina. 3. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina. 4. Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. 5. Hospital Materno Infantil Ramón Sarda, Buenos Aires, Argentina.
Abstract
BACKGROUND: Asthma and wheezing account for a substantial disease burden around the world. Very low birth weight (VLBW, <1500 grams) infants are at an increased risk for the development of severe acute respiratory illness (ARI) and recurrent wheeze/asthma. The role of respiratory viruses in asthma predisposition in premature infants is not well understood. Preliminary evidence suggests that infection with human rhinovirus (RV) early in life may contribute to greater burden of asthma later in life. METHODS: A prospective cohort study of premature VLBW infants from Buenos Aires, Argentina, was enrolled year-round during a three-year period in the neonatal intensive care unit and followed during every ARI and with monthly well visits during the first year of life. Longitudinal follow-up up until age five years is ongoing. RESULTS: This report describes the objectives, design, and recruitment results of this prospective cohort. Two hundred and five patients were enrolled from August 2011 through January 2014, and follow-up is ongoing. A total of 319 ARI episodes were observed from August 2011 to July 2014, and 910 well visits occurred during this time period. CONCLUSIONS: The Argentina Premature Asthma and Respiratory Team (APART) is a unique cohort consisting of over 200 patients and over 1200 specimens who have been and will continue to be followed intensively from NICU discharge to capture baseline risk factors and every ARI, with interceding well visits during the first year of life, as well as longitudinal follow-up to age 5 years for asthma and atopy outcomes.
BACKGROUND: Asthma and wheezing account for a substantial disease burden around the world. Very low birth weight (VLBW, <1500 grams) infants are at an increased risk for the development of severe acute respiratory illness (ARI) and recurrent wheeze/asthma. The role of respiratory viruses in asthma predisposition in premature infants is not well understood. Preliminary evidence suggests that infection with human rhinovirus (RV) early in life may contribute to greater burden of asthma later in life. METHODS: A prospective cohort study of premature VLBW infants from Buenos Aires, Argentina, was enrolled year-round during a three-year period in the neonatal intensive care unit and followed during every ARI and with monthly well visits during the first year of life. Longitudinal follow-up up until age five years is ongoing. RESULTS: This report describes the objectives, design, and recruitment results of this prospective cohort. Two hundred and five patients were enrolled from August 2011 through January 2014, and follow-up is ongoing. A total of 319 ARI episodes were observed from August 2011 to July 2014, and 910 well visits occurred during this time period. CONCLUSIONS: The Argentina Premature Asthma and Respiratory Team (APART) is a unique cohort consisting of over 200 patients and over 1200 specimens who have been and will continue to be followed intensively from NICU discharge to capture baseline risk factors and every ARI, with interceding well visits during the first year of life, as well as longitudinal follow-up to age 5 years for asthma and atopy outcomes.
Authors: E Kathryn Miller; Jimena Bugna; Romina Libster; Bryan E Shepherd; Paula M Scalzo; Patricio L Acosta; Diego Hijano; Natalia Reynoso; Juan P Batalle; Silvina Coviello; M Ines Klein; Gabriela Bauer; Alicia Benitez; Steven R Kleeberger; Fernando P Polack Journal: Pediatrics Date: 2011-12-26 Impact factor: 7.124
Authors: E E Wang; B J Law; F D Boucher; D Stephens; J L Robinson; S Dobson; J M Langley; J McDonald; N E MacDonald; I Mitchell Journal: J Pediatr Date: 1996-09 Impact factor: 4.406
Authors: Simon B Drysdale; Mireia Alcazar; Theresa Wilson; Melvyn Smith; Mark Zuckerman; Catherine J Wedderburn; Simon Broughton; Gerrard F Rafferty; Sebastian L Johnston; Anne Greenough Journal: Pediatr Infect Dis J Date: 2012-01 Impact factor: 2.129
Authors: Anne Kotaniemi-Syrjänen; Raija Vainionpää; Tiina M Reijonen; Matti Waris; Kaj Korhonen; Matti Korppi Journal: J Allergy Clin Immunol Date: 2003-01 Impact factor: 10.793